Roble, Belko & Company, Inc Becton Dickinson & CO Transaction History

Roble, Belko & Company, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$218.29 - $256.91 $8,295 - $9,762	-38 Reduced 40.86%	55 $14,000
Q3 2020 Nov 10, 2020	BUY	$215.77 - $276.76 $8,199 - $10,516	38 Added 69.09%	93 $22,000
Q2 2020 Aug 10, 2020	SELL	$219.9 - $263.41 $10,775 - $12,907	-49 Reduced 47.12%	55 $13,000
Q3 2017 Nov 08, 2017	BUY	$186.89 - $198.9 $19,436 - $20,685	104	104 $20,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Roble, Belko & Company, Inc with notifications on news.